IMMUTEP LTD (IMMP)
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
Aptiv’s Winchester Interconnect Launches VITA 67.2 RF Connector Product Line for High-Density Aerospace and Defense Systems
Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules
Evolv Technology and Philadelphia Phillies Expand Partnership with Multi-Year Renewal of Evolv Express®
Zhongchao Inc. Announces 1-for-31 Share Consolidation
Visa and Brale Explore Private Stablecoin Settlement for Institutional Payments
PepsiCo Announces Timing and Availability of Second-Quarter 2026 Financial Results
Pure Harvest Corporate Group (OTC: PHCG), Operating as Mixie Technologies, Announces HoloTwin 2.0 Framework for Large-Scale 3D Visualization in the Browser
Delta and American Express Add More Travel Value to Delta SkyMiles Cards
IMUNON Announces Up to $10 Million Cash Financing